Navigation Links
Antidepressant Eases Anxiety in Older Adults
Date:1/20/2009

Other SSRIs would probably be equally effective, researchers report

TUESDAY, Jan. 20 (HealthDay News) -- Older adults with generalized anxiety disorder treated with the antidepressant Lexapro showed significant improvement in symptoms, a new study reports.

Generalized anxiety disorder is one of the most common psychiatric disorders in older adults. Its symptoms include chronic worry and anxiety and other problems, such as muscle tension, sleep disturbance and fatigue.

"This was the first large-scale study of antidepressant medications as a treatment for anxiety disorders in older adults," said lead researcher Dr. Eric J. Lenze, an associate professor of psychiatry at Washington University School of Medicine in St. Louis.

As many as 7.3 percent of older people suffer from anxiety, and the percent is even higher among those receiving medical care, Lenze said. People with general anxiety can spend up to 40 hours a week consumed by worry, he added.

For many years, the treatment for anxiety in older adults has been either no treatment or such sedatives as Valium (diazepam) or Xanax (alprazolam), Lenze said. "There have been concerns about the safety of these medications in older adults," he added.

Lexapro (escitalopram) is in a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs), which are thought to be safer, Lenze said. These drugs are approved for treating anxiety, he noted.

Although the researchers used Lexapro for this study, Lenze believes that other SSRIs would produce the same beneficial effect.

For the study, Lenze's team tested the effectiveness of Lexapro in 177 adults 60 and older suffering from general anxiety disorder. The participants were randomly assigned to Lexapro or a placebo for 12 weeks.

The result: 69 percent of people taking Lexapro saw reductions in their anxiety levels, compared with 51 percent of those taking a placebo. Those on Lexapro also had greater improvement in functioning, activity and social functioning, the study found.

The researchers also found that people with high blood pressure taking Lexapro had a significant decrease in blood pressure. "This may suggest some additional health-related benefits of getting treatment for anxiety in this age group," Lenze said, adding, "There are effective treatments for anxiety in older adults other than sedatives."

The study results were published in the Jan. 21 issue of the Journal of the American Medical Association.

Lenze said he hopes this study will help raise awareness that anxiety disorders are common among older people, and are often undetected or treated only with sedatives.

Douglas Mennin, an assistant professor of psychology at Yale University, agrees that physicians should be alert to anxiety problems among their older patients.

"Older adults should certainly be asked about their anxiety," Mennin said. "Many older adults are faced with increasingly stressful situations, such as loss of friends, mobility and job, and anxiety is a natural result," he said.

More information

For more information on anxiety, visit the U.S. National Institute of Mental Health.



SOURCES: Eric J. Lenze, M.D., associate professor of psychiatry, Washington University School of Medicine, St. Louis; Douglas Mennin, Ph.D., assistant professor of psychology, Yale University, New Haven, Conn.; Jan. 21, 2009, Journal of the American Medical Association


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Certain Antidepressants Ease Fibromyalgia Symptoms
2. Pregnancy study finds strong association between two antidepressants and heart anomalies
3. Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules
4. 2nd Generation Antidepressants Prove Effective
5. Response rates to antidepressants differ among English- and Spanish-speaking Hispanics
6. Lyriana Announces Antidepressants Now Linked to Declining Libido in Women
7. Antidepressant Scripts Up 16 Million Over 3-Year Period
8. Gene Variations May Predict Antidepressant Response
9. New study replicates association between genetic variation and antidepressant treatment response
10. Do Antidepressants Make Bones Brittle?
11. Antidepressants in suicide prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... Angeles, California (PRWEB) , ... May 26, 2017 , ... ... senior citizens who visit a doctor for colds or respiratory issues that are not ... that excessive time pressure on doctors may be largely responsible for the problem both ...
(Date:5/27/2017)... ... , ... Most us are familiar with the sound of occasional popping joints ... Initiative shows that certain people who experience consistent joint popping, grating and grinding ... the opportunity to treat patients before the problem becomes pronounced, potentially hedging off more ...
(Date:5/26/2017)... ... May 26, 2017 , ... The ... educational seminar to focus on current legislative activity and the latest regulatory concerns ... 1 p.m. Sunday, Sept. 10, and will continue through Monday, Sept. 11, at ...
(Date:5/26/2017)... ... 2017 , ... Boar’s Head Brand®, one of the nation’s ... entertaining that are sure to satisfy your guests’ flavor cravings, while adding delicious ... featured in these refreshingly balanced recipes are packed with flavor, creating the perfect ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Yisrayl Hawkins, ... new publication this week that is focusing on the Peace Agreements being discussed by ... Middle East sprint in a race to try to speed up peace talks in ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... May 22, 2017  As the specialty pharmacy ... continue to make the revolutionary shift from volume-based ... for ensuring positive patient outcomes and shaping the ... shifting focus away from clinical trials and toward ... long-term specialty drug therapy utilization in precise patient ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
Breaking Medicine Technology: